CN1498112A - 雌激素依赖性疾病的联合治疗 - Google Patents

雌激素依赖性疾病的联合治疗 Download PDF

Info

Publication number: CN1498112A
Authority: CN; China
Prior art keywords: cancer; aromatase inhibitor; triptorelin; lhrh agonist; exemestane
Prior art date: 2000-11-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CNA018189385A

Other languages

English (en)

Chinese (zh)

Inventor

ϣ�¶�

迪内希·普兰德尔

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pharmacia and Upjohn Co

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-16

Filing date

2001-11-06

Publication date

2004-05-19

2001-11-06 Application filed by Upjohn Co filed Critical Upjohn Co

2004-05-19 Publication of CN1498112A publication Critical patent/CN1498112A/zh

Status Pending legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CNA018189385A 2000-11-16 2001-11-06 雌激素依赖性疾病的联合治疗 Pending CN1498112A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US71460500A	2000-11-16	2000-11-16
US09/714,605		2000-11-16

Publications (1)

Publication Number	Publication Date
CN1498112A true CN1498112A (zh)	2004-05-19

Family

ID=24870727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CNA018189385A Pending CN1498112A (zh)	2000-11-16	2001-11-06	雌激素依赖性疾病的联合治疗

Country Status (16)

Country	Link
EP (1)	EP1341549A2 (cs)
JP (1)	JP2004536022A (cs)
KR (1)	KR20030051828A (cs)
CN (1)	CN1498112A (cs)
AU (1)	AU2002230464A1 (cs)
BR (1)	BR0115423A (cs)
CA (1)	CA2428249A1 (cs)
CZ (1)	CZ20031349A3 (cs)
EA (1)	EA200300572A1 (cs)
IL (1)	IL155817A0 (cs)
MX (1)	MXPA03004195A (cs)
NO (1)	NO20032206L (cs)
NZ (1)	NZ525720A (cs)
PL (1)	PL365904A1 (cs)
WO (1)	WO2002039995A2 (cs)
ZA (1)	ZA200303669B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101775054B (zh) *	2010-02-05	2012-12-26	常州佳尔科药业集团有限公司	4-羟基-4-烯-3-酮甾族化合物的合成方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL153218A0 (en)	2000-06-02	2003-07-06	Univ Texas	Ethylenedicysteine (ec) -drug conjugates
US9050378B2 (en)	2003-12-10	2015-06-09	Board Of Regents, The University Of Texas System	N2S2 chelate-targeting ligand conjugates
GB0506759D0 (en) *	2005-04-02	2005-05-11	Medical Res Council	Combination treatment methods
EP1891964A1 (en) *	2006-08-08	2008-02-27	AEterna Zentaris GmbH	Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
US10925977B2 (en)	2006-10-05	2021-02-23	Ceil>Point, LLC	Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
US20080261933A1 (en) *	2007-04-23	2008-10-23	Jens Hoffmann	Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9911582D0 (en) *	1999-05-18	1999-07-21	Pharmacia & Upjohn Spa	Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound
GB9930839D0 (en) *	1999-12-30	2000-02-16	Pharmacia & Upjohn Spa	Process for treating gynecomastia

2001
- 2001-11-06 KR KR10-2003-7006608A patent/KR20030051828A/ko not_active Withdrawn
- 2001-11-06 EA EA200300572A patent/EA200300572A1/ru unknown
- 2001-11-06 CZ CZ20031349A patent/CZ20031349A3/cs unknown
- 2001-11-06 AU AU2002230464A patent/AU2002230464A1/en not_active Abandoned
- 2001-11-06 BR BR0115423-0A patent/BR0115423A/pt not_active IP Right Cessation
- 2001-11-06 NZ NZ525720A patent/NZ525720A/en unknown
- 2001-11-06 PL PL01365904A patent/PL365904A1/xx not_active Application Discontinuation
- 2001-11-06 MX MXPA03004195A patent/MXPA03004195A/es unknown
- 2001-11-06 IL IL15581701A patent/IL155817A0/xx unknown
- 2001-11-06 EP EP01990699A patent/EP1341549A2/en not_active Withdrawn
- 2001-11-06 CN CNA018189385A patent/CN1498112A/zh active Pending
- 2001-11-06 JP JP2002542370A patent/JP2004536022A/ja active Pending
- 2001-11-06 WO PCT/US2001/043847 patent/WO2002039995A2/en not_active Ceased
- 2001-11-06 CA CA002428249A patent/CA2428249A1/en not_active Abandoned
2003
- 2003-05-13 ZA ZA200303669A patent/ZA200303669B/en unknown
- 2003-05-15 NO NO20032206A patent/NO20032206L/no not_active Application Discontinuation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101775054B (zh) *	2010-02-05	2012-12-26	常州佳尔科药业集团有限公司	4-羟基-4-烯-3-酮甾族化合物的合成方法

Also Published As

Publication number	Publication date
CZ20031349A3 (cs)	2004-05-12
KR20030051828A (ko)	2003-06-25
NO20032206L (no)	2003-07-15
JP2004536022A (ja)	2004-12-02
NO20032206D0 (no)	2003-05-15
NZ525720A (en)	2006-12-22
BR0115423A (pt)	2005-12-13
EP1341549A2 (en)	2003-09-10
AU2002230464A1 (en)	2002-05-27
CA2428249A1 (en)	2002-05-23
EA200300572A1 (ru)	2004-06-24
PL365904A1 (en)	2005-01-10
IL155817A0 (en)	2003-12-23
MXPA03004195A (es)	2003-09-22
WO2002039995A9 (en)	2003-02-06
WO2002039995A2 (en)	2002-05-23
ZA200303669B (en)	2004-05-13
WO2002039995A3 (en)	2003-05-01

Similar Documents

Publication	Publication Date	Title
EP0195015B1 (en)	1992-05-13	Pharmaceutical composition for combination therapy of hormone dependent cancers
US4760053A (en)	1988-07-26	Combination therapy for selected sex steroid dependent cancers
CA1278515C (en)	1991-01-02	Pharmaceutical composition for combination therapy of hormone dependent cancers
US4666885A (en)	1987-05-19	Combination therapy for treatment of female breast cancer
US6096764A (en)	2000-08-01	Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
JP2006502969A (ja)	2006-01-26	内因性性腺刺激ホルモン産生の増強
CN1126566C (zh)	2003-11-05	促黄体素释放激素拮抗剂用于制备治疗前列腺肥大和前列腺癌的药物的用途
US20060287241A1 (en)	2006-12-21	Combination comprising N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonate
CN1209750A (zh)	1999-03-03	由lhrh类似物和抗雌激素构成的联合药物制剂用以治疗妇科疾病
CN1498112A (zh)	2004-05-19	雌激素依赖性疾病的联合治疗
CN1137722C (zh)	2004-02-11	为长期治疗方案确立基础(tonic)卵巢雌激素分泌
US5023234A (en)	1991-06-11	Combination male breast cancer therapy
Klijn	1992	LH-RH agonists in the treatment of metastatic breast cancer: ten years’ experience
CN114903902A (zh)	2022-08-16	GnRH受体拮抗剂联合雄激素受体拮抗剂在制备治疗前列腺癌药物中的用途
US20120004182A1 (en)	2012-01-05	Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells
WO2002039996A2 (en)	2002-05-23	Combined therapy against tumors comprising estramustine phosphate and lhrh agonists or antagonists
EP1297850B1 (en)	2015-08-19	Medicinal preparations for treating sex hormone-dependent diseases
EP3560555A1 (en)	2019-10-30	A composition for treating one or more estrogen related diseases
US20040043938A1 (en)	2004-03-04	Combination therapy for estrogen-dependent disorders
HK1066169A (en)	2005-03-18	Combination therapy for estrogen-dependent disorders
CA1278748C (en)	1991-01-08	Pharmaceutical composition for combination therapy of hormone dependent cancers
EP1092438B1 (en)	2006-06-14	Pharmaceutical compositions containing growth-hormone inhibitors or their biologically active fragments for the treatment of uterine myomas
Forti	1988	Clinicai applications of GnRH analogs
Engel et al.	2003	Luteinizing hormone-releasing hormone antagonists in gynecology
HU199694B (en)	1990-03-28	Process for producing citostatic pharmaceutical compositions containing gonadoliberin derivatives

Legal Events

Date	Code	Title	Description
2004-05-19	C06	Publication
2004-05-19	PB01	Publication
2004-07-28	C10	Entry into substantive examination
2004-07-28	SE01	Entry into force of request for substantive examination
2005-03-18	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1066169 Country of ref document: HK
2007-06-27	C02	Deemed withdrawal of patent application after publication (patent law 2001)
2007-06-27	WD01	Invention patent application deemed withdrawn after publication
2011-06-24	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1066169 Country of ref document: HK